The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy
Mao‐xu Ge(Chinese Academy of Medical Sciences & Peking Union Medical College), Rong‐Guang Shao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 65
Related Papers
CD133<sup>+</sup>EpCAM<sup>+</sup> Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells
|International Journal of Biological Sciences|2012|96
<scp>GAP</scp>161 targets and downregulates <scp>G</scp>3<scp>BP</scp> to suppress cell growth and potentiate cisplaitin‐mediated cytotoxicity to colon carcinoma <scp>HCT</scp>116 cells
|Cancer Science|2012|69
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters
|Acta Pharmacologica Sinica|2018|37
Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats
|World Journal of Gastroenterology|2015|36